Time

Event

8:00 am – Lobby Level

Registration Opens

8:00 am – Lobby Level

One-to-One Meetings 

8:55 am – 2nd Floor

Welcome Back 

• Sara Jane Demy, Founder & CEO, Demy-Colton

9:00 am – 2nd Floor

“Big Think" Plenary Session  

Adjusting to the New Reality 

Panel: 

• Jennifer Hawks Bland, CEO, NewYorkBIO
• Cartier Esham, CEO, Esham Strategies
• Nancy Myers, CEO & Founder, Catalyst Healthcare Consulting 
• Peter Rubin, Executive Director, No Patient Left Behind 

10:00 am – Lobby Level

One-to-One Meetings

10:00 am – 2nd Floor

Dialogue 4A 

AI: From Target and Lead Discovery to Clinical Trials and Personalized Medicine – Revolutionizing Drug Development 

Panel: 

• Maria Pineda, CEO & Co-Founder, Envisagenics 

11:00 am – 2nd Floor

Seed Pitch Doctor Presentations 

Pitch Doctors:

• Michael Langer, Co-Founder & Managing Partner, T.Rx Capital

12:15 pm – 2nd Floor & Lobby Level

Lunch

1:15 pm – 2nd Floor

“Big Think” Plenary Session 

Venture Investment in Early-Stage Biopharma: Are We Seeing Signs of Recovery?

Moderator:

• Kelliann Payne, Partner, Global Regulatory, Hogan Lovells

Panel:

• Michael Langer, Co-Founder & Managing Partner, T.Rx Capital
• Jarod Rutledge, Director, Biotechnology & Life Sciences, Starbloom Capital

2:15 pm – 2nd Floor

Closing “Big Think” Plenary Session 

Heard Around the Street: What’s Buzzing in Biopharma       

Moderator:  

• Virginia Amman, CEO & Founder, ENTENTE Networks 

Panel:

• Adam Bluestein, Contributor, Fast Company

3:00 pm

Closing Reception